GlaxoSmithKline

GlaxoSmithKlineGlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.

GlaxoSmithKline RSS Channel

Title Filter      Display #  
# Article Title
1 Where do you start when developing a new medicine?
2 GSK increases stake in Indian Pharmaceuticals subsidiary to 75 %
3 Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation
4 GSK adds detailed clinical trial data to multi-sponsor request system
5 GSK responds to FDA decision on Avandia (rosiglitazone)
6 H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure
7 Five inspirational organisations from Malawi, Bangladesh, Mali, Kenya, and Colombia recognised by GSK and Save the Children
8 GSK names inaugural winners in unique competition for academic drug hunters
9 New partnership between GSK and the Bill & Melinda Gates Foundation to accelerate research into vaccines for global health needs
10 GSK and Genmab announce submission to US regulatory authorities for Arzerra® (ofatumumab)
11 GSK signs a multi-year agreement with BARDA to supply the US government with anthrax treatment
12 GSK launches $50 million venture capital fund to invest in pioneering bioelectronic medicines and technologies
13 GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases
14 GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma
15 GSK and Save the Children launch $1 million award to discover new healthcare innovations for reducing child deaths
16 GSK and Save the Children form unique partnership to save the lives of one million children
17 Funding boost for GSK's open innovation research into diseases affecting the developing world
18 $500,000 endowment gift from the GlaxoSmithKline Foundation
19 ViiV Healthcare announces FDA priority review designation for dolutegravir
20 GSK response to news article in The Guardian on UK legal proceedings related to Avandia
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]